Archives
-
FLCN Variants and mRNA Rescue in Birt-Hogg-Dubé
2026-09-24
A study of two Chinese families links FLCN variants p.W376R and p.Q44* to Birt-Hogg-Dubé syndrome and reports that synthetic FLCN mRNA restored protein expression and corrected mTORC1 dysregulation in cultured cells. The findings add genetic and functional evidence for variant interpretation while positioning mRNA supplementation as an early, in vitro research direction—not an established treatment.
-
Protease Inhibitor Cocktail for OXPHOS Assays
2026-09-23
A Protease Inhibitor Cocktail can help preserve protein integrity in OXPHOS research, but it cannot substitute for careful assay design. Learn how an EDTA-Free Protease Inhibitor supports interpretable protein measurements alongside studies of dual-genome metabolic disruption.
-
Amikacin disulfate: Research Workflows
2026-09-23
Build mechanism-first experiments that connect 16S rRNA targeting, bacterial protein synthesis suppression, and antibiotic resistance research with orthogonal protein-binding assays. This guide translates recent lysozyme-complexation findings into practical, water-based workflows and troubleshooting decisions for reproducible bench studies.
-
NVP-BGJ398 Phosphate: From Signal to Phenotype
2026-09-22
NVP-BGJ398 phosphate is a selective FGFR1–3 inhibitor that connects genotype-defined cancer models with FGFR3-dependent skeletal research. This article explains how to convert pathway suppression into rigorous, phenotype-level evidence using orthogonal assays.
-
NVP-BGJ398 phosphate: FGFR Research Workflows
2026-09-22
NVP-BGJ398 phosphate enables mechanism-focused inhibition of FGFR1–3 across cancer, chondrocyte, and signaling assays. This practical guide connects genotype-aware screening with phospho-FGFR and ERK1/2 validation, while addressing dosing, solubility, and assay reproducibility.
-
ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors
2026-09-21
The reference study identifies ATRX deficiency as a potential biomarker of increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination experiments further suggest that pairing these inhibitors with temozolomide may intensify toxicity in ATRX-deficient models, supporting ATRX-aware interpretation of translational studies.
-
DPPH Antioxidant Screening: Workflow & Tips
2026-09-21
Build a reproducible DPPH workflow for rapid in vitro antioxidant screening, natural-product prioritization, and high-throughput compound comparison. Practical solvent guidance, plate controls, and troubleshooting help distinguish true radical scavenging from color, precipitation, and matrix artifacts.
-
Cabamiquine Pharmacodynamics: Fast Arrest, Slow Clearance
2026-09-20
The reference study separates cabamiquine-induced translational arrest from subsequent parasite killing using complementary luminescence, viability, growth, and live-imaging assays. Its findings explain how a drug can act rapidly at the molecular level while producing delayed blood-stage clearance, an important distinction for interpreting antimalarial pharmacodynamics.
-
KNUCKLES Controls Floral Meristem Termination
2026-09-19
The Arabidopsis study shows that KNUCKLES terminates floral meristem activity by coordinating the established WUS–CLV3 stem-cell circuit with auxin distribution and cytokinin biosynthesis. Its central advance is the identification of PIN1 and IPT7 as chromatin-linked targets through which KNU-associated H3K27me3 deposition helps impose floral determinacy.
-
PPARγ, Macrophage Polarization, and DSS-Induced IBD
2026-09-18
This study identifies PPARγ activation as a regulator of macrophage polarization in dextran sulfate sodium-induced inflammatory bowel disease, linking reduced M1 activity and enhanced M2 features to reciprocal changes in STAT-1 and STAT-6 signaling. Its combined cell and mouse experiments provide a mechanistic framework for studying inflammatory process modulation, while also highlighting the limits of translating a chemically induced model into human IBD.
-
mRNA Vaccine Immune Memory and LNP Design
2026-09-18
The reference study shows that durable mRNA vaccine protection depends on strengthening immune memory against tumor antigens while limiting memory directed toward lipid nanoparticles. Its SAPC-LNP design combines sialic acid-mediated dendritic-cell targeting with cleavable PEG to improve endosomal escape, reduce repeated-dose liabilities, and sustain antitumor protection.
-
Annexin V-FITC/7-AAD Apoptosis Kit Workflow
2026-09-17
Build a rapid cell death analysis workflow that separates viable, early apoptotic, late apoptotic, and necrotic populations in one assay. The approach also shows how lactoferrin-processing studies can be translated into practical cell viability and cytotoxicity readouts without overstating what Annexin V can prove mechanistically.
-
E. tenella Drugs, Cecal Microbiota, and Metabolomics
2026-09-17
The reference study combines 16S rRNA gene sequencing with LC-MS/MS metabolomics to examine how ethanamizuril, sulfachlorpyridazine, and their combination affect chickens infected with Eimeria tenella. Its main contribution is a systems-level view of anticoccidial efficacy, showing that treatment-associated microbial and metabolic changes can provide context for interpreting intestinal health and drug response.
-
Nirmatrelvir (PF-07321332) Research Workflows
2026-09-16
Build mechanism-first SARS-CoV-2 assays around Nirmatrelvir (PF-07321332), from 3CL protease cleavage measurements to cell-based replication studies. This guide combines practical handling, assay controls, docking-informed validation, and troubleshooting for antiviral therapeutics research.
-
Praeruptorin A: From Target to Translational Assay
2026-09-16
Praeruptorin A is an angular pyranocoumarin compound that links DMT1-dependent iron handling with ferroptosis, inflammation, and tissue injury. This article presents a decision-based framework for selecting assays, interpreting orthogonal readouts, and translating findings across cardiomyopathy, colitis, and tumor-invasion models.